#orsiro

BIOTRONIK’s Orsiro Ultrathin Coronary Stent Approved in U.S.

BIOTRONIK’s Orsiro Ultrathin Coronary Stent Approved in U.S.

BIOTRONIK won FDA approval for its Orsiro drug-eluting coronary stent, an ultrathin device that’s already been approved in Europe for eight years and has been implanted in more than a million patients worldwide.

The Orsiro is a cobalt chromium metal stent that releases sirolimus, which helps to prevent restenosis. This is…

BIOTRONIK’s Orsiro Ultrathin Coronary Stent Approved in U.S.

BIOTRONIK’s Orsiro Ultrathin Coronary Stent Approved in U.S.

BIOTRONIK won FDA approval for its Orsiro drug-eluting coronary stent, an ultrathin device that’s already been approved in Europe for eight years and has been implanted in more than a million patients worldwide.

The Orsiro is a cobalt chromium metal stent that releases sirolimus, which helps to prevent restenosis. This is…

BIOTRONIK’s Orsiro Ultrathin Coronary Stent Approved in U.S.

BIOTRONIK’s Orsiro Ultrathin Coronary Stent Approved in U.S.

BIOTRONIK won FDA approval for its Orsiro drug-eluting coronary stent, an ultrathin device that’s already been approved in Europe for eight years and has been implanted in more than a million patients worldwide.

The Orsiro is a cobalt chromium metal stent that releases sirolimus, which helps to prevent restenosis. This is…